rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

QVT Financial LP

Other role

Company insider

Files Form 4 as: Other, Okeanis Eco Tankers; Director and 10% owner and Other, Roivant Sciences; Director, MP Materials.

In numbers

Trades disclosed
233
Buys
0
Sells
56
Bought
$0
Sold
$751.9M
Companies
3
Companies where not an officer
3
First trade
21 Dec 2020
Last trade
14 Aug 2026
Last filed
17 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ECO Okeanis Eco TankersOther · Marine Shipping · last 14 Aug 20260 buys · 2 sells
ROIV Roivant SciencesDirector, 10% owner, Other · Biotechnology · last 30 Jun 20260 buys · 13 sells
MP MP MaterialsDirector · Rare Earths & Critical Minerals · last 14 Dec 20220 buys · 41 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 17 Aug 2026ECO Okeanis Eco TankersMarine ShippingSEC FORM 4 Sold$4.1M68,420 at $59.99filing
14 Aug 2026filed 17 Aug 2026ECO Okeanis Eco TankersMarine ShippingSEC FORM 4 Sold$4.1M68,420 at $59.99filing
13 Aug 2026filed 17 Aug 2026ECO Okeanis Eco TankersMarine ShippingSEC FORM 4 Sold$555K8,539 at $65.04filing
13 Aug 2026filed 17 Aug 2026ECO Okeanis Eco TankersMarine ShippingSEC FORM 4 Sold$555K8,539 at $65.04filing
30 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$437K12,380 at $35.28filing
30 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$437K12,380 at $35.28filing
29 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$6.9M200,000 at $34.44filing
29 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$20.8M600,000 at $34.59filing
29 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$6.9M200,000 at $34.44filing
29 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$20.8M600,000 at $34.59filing
26 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$10.2M300,783 at $33.92filing
26 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$11.1M325,000 at $34.07filing
26 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$10.2M300,783 at $33.92filing
26 Jun 2026filed 30 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$11.1M325,000 at $34.07filing
13 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$4.0M150,784 at $26.49filing
13 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$6.0M225,000 at $26.50filing
13 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$4.0M150,784 at $26.49filing
13 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$6.0M225,000 at $26.50filing
12 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$4.0M150,000 at $26.72filing
12 Feb 2026filed 13 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$7.4M275,000 at $26.76filing

News

Sectors

Materials41
Health Care13
Industrials2

Buys in green, sells in red, by the company’s sector.

Related people

Eric VenkerPresident & Immunovant CEO · President & Immunovant CEO at Roivant Sciences, filing Form 4 there in the last year
Matthew GlineCEO · CEO at Roivant Sciences, filing Form 4 there in the last year
Mayukh SukhatmePresident & CIO · President & CIO at Roivant Sciences, filing Form 4 there in the last year
Epperly Melissa BDirector · Director at Roivant Sciences, filing Form 4 there in the last year
Frank TortiPresident and Vant Chair · President and Vant Chair at Roivant Sciences, filing Form 4 there in the last year
Meghan FitzgeraldDirector · Also traded ROIV in the last 90 days
Daniel Allen GoldDirector · Also traded ECO in the last 90 days